FDA Approved: TOBRAMYCIN AND DEXAMETHASONE — Supplemental Application (Bausch & Lomb Incorporated)

View source ↗

Summary

FDA approved a supplemental application for Tobramycin and Dexamethasone (Bausch & Lomb Incorporated), authorizing changes to the product's labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bacterial Conjunctivitis

Drugs mentioned

• TOBRAMYCIN AND DEXAMETHASONE (tobramycin and dexamethasone)

Snippet

SUPPL AP for TOBRAMYCIN AND DEXAMETHASONE (TOBRAMYCIN AND DEXAMETHASONE)